Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study

BACKGROUND: People living with HIV might have a poor or delayed response to vaccines, mainly when CD4 cell counts are low, and data concerning COVID-19 vaccines in this population are scarce. This prospective cohort study assessed the safety and immunogenicity of the inactivated SARS-CoV-2 vaccine C...

Descripción completa

Detalles Bibliográficos
Autores principales: Netto, Lucas C, Ibrahim, Karim Y, Picone, Camila M, Alves, Ana Paula P S, Aniceto, Eliane V, Santiago, Mariana R, Parmejani, Patrícia S S, Aikawa, Nadia E, Medeiros-Ribeiro, Ana C, Pasoto, Sandra G, Yuki, Emily F N, Saad, Carla G S, Pedrosa, Tatiana, Lara, Amanda N, Ceneviva, Carina, Bonfa, Eloisa, Kallas, Esper G, Avelino-Silva, Vivian I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942475/
https://www.ncbi.nlm.nih.gov/pubmed/35338835
http://dx.doi.org/10.1016/S2352-3018(22)00033-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942475/
https://www.ncbi.nlm.nih.gov/pubmed/35338835
http://dx.doi.org/10.1016/S2352-3018(22)00033-9

Ejemplares similares